• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度生成神经网络在药物反应预测中的应用

Deep generative neural network for accurate drug response imputation.

机构信息

Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.

出版信息

Nat Commun. 2021 Mar 19;12(1):1740. doi: 10.1038/s41467-021-21997-5.

DOI:10.1038/s41467-021-21997-5
PMID:33741950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7979803/
Abstract

Drug response differs substantially in cancer patients due to inter- and intra-tumor heterogeneity. Particularly, transcriptome context, especially tumor microenvironment, has been shown playing a significant role in shaping the actual treatment outcome. In this study, we develop a deep variational autoencoder (VAE) model to compress thousands of genes into latent vectors in a low-dimensional space. We then demonstrate that these encoded vectors could accurately impute drug response, outperform standard signature-gene based approaches, and appropriately control the overfitting problem. We apply rigorous quality assessment and validation, including assessing the impact of cell line lineage, cross-validation, cross-panel evaluation, and application in independent clinical data sets, to warrant the accuracy of the imputed drug response in both cell lines and cancer samples. Specifically, the expression-regulated component (EReX) of the observed drug response achieves high correlation across panels. Using the well-trained models, we impute drug response of The Cancer Genome Atlas data and investigate the features and signatures associated with the imputed drug response, including cell line origins, somatic mutations and tumor mutation burdens, tumor microenvironment, and confounding factors. In summary, our deep learning method and the results are useful for the study of signatures and markers of drug response.

摘要

由于肿瘤内和肿瘤间的异质性,癌症患者的药物反应有很大的差异。特别是转录组背景,尤其是肿瘤微环境,已被证明在塑造实际治疗结果方面起着重要作用。在这项研究中,我们开发了一个深度变分自动编码器(VAE)模型,将数千个基因压缩到低维空间中的潜在向量中。然后,我们证明这些编码向量可以准确地推断药物反应,优于基于标准特征基因的方法,并适当控制过拟合问题。我们应用严格的质量评估和验证,包括评估细胞系谱系的影响、交叉验证、跨面板评估以及在独立临床数据集的应用,以保证推断的药物反应在细胞系和癌症样本中的准确性。具体来说,观察到的药物反应的表达调节成分(EReX)在面板之间具有高度相关性。使用经过良好训练的模型,我们推断了癌症基因组图谱数据的药物反应,并研究了与推断的药物反应相关的特征和标记物,包括细胞系起源、体细胞突变和肿瘤突变负担、肿瘤微环境和混杂因素。总之,我们的深度学习方法和结果对于药物反应的特征和标记物的研究是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/1a4987a419e7/41467_2021_21997_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/84de26b7d9e0/41467_2021_21997_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/e4e707587f9e/41467_2021_21997_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/aa46fbf632e7/41467_2021_21997_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/1b46b3e58784/41467_2021_21997_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/a5f69fdd9f6f/41467_2021_21997_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/027178f65489/41467_2021_21997_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/8633a22c9e35/41467_2021_21997_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/1a4987a419e7/41467_2021_21997_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/84de26b7d9e0/41467_2021_21997_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/e4e707587f9e/41467_2021_21997_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/aa46fbf632e7/41467_2021_21997_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/1b46b3e58784/41467_2021_21997_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/a5f69fdd9f6f/41467_2021_21997_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/027178f65489/41467_2021_21997_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/8633a22c9e35/41467_2021_21997_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/7979803/1a4987a419e7/41467_2021_21997_Fig8_HTML.jpg

相似文献

1
Deep generative neural network for accurate drug response imputation.深度生成神经网络在药物反应预测中的应用
Nat Commun. 2021 Mar 19;12(1):1740. doi: 10.1038/s41467-021-21997-5.
2
Predicting chemotherapy response using a variational autoencoder approach.使用变分自动编码器方法预测化疗反应。
BMC Bioinformatics. 2021 Sep 22;22(1):453. doi: 10.1186/s12859-021-04339-6.
3
Prediction of cancer dependencies from expression data using deep learning.利用深度学习从表达数据预测癌症依赖性。
Mol Omics. 2021 Feb 1;17(1):66-71. doi: 10.1039/d0mo00042f. Epub 2020 Nov 2.
4
Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.基于深度学习模型整合多组学数据进行协同药物组合预测。
Methods Mol Biol. 2021;2194:223-238. doi: 10.1007/978-1-0716-0849-4_12.
5
Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network.利用深度卷积网络提高癌症细胞系表型药物反应预测。
BMC Bioinformatics. 2019 Jul 29;20(1):408. doi: 10.1186/s12859-019-2910-6.
6
Extracting a biologically relevant latent space from cancer transcriptomes with variational autoencoders.使用变分自编码器从癌症转录组中提取生物学相关的潜在空间。
Pac Symp Biocomput. 2018;23:80-91.
7
SWnet: a deep learning model for drug response prediction from cancer genomic signatures and compound chemical structures.SWnet:一种基于癌症基因组特征和化合物化学结构预测药物反应的深度学习模型。
BMC Bioinformatics. 2021 Sep 10;22(1):434. doi: 10.1186/s12859-021-04352-9.
8
Semisupervised Generative Autoencoder for Single-Cell Data.半监督生成式自动编码器用于单细胞数据。
J Comput Biol. 2020 Aug;27(8):1190-1203. doi: 10.1089/cmb.2019.0337. Epub 2019 Dec 2.
9
Selecting precise reference normal tissue samples for cancer research using a deep learning approach.使用深度学习方法为癌症研究选择精确的参考正常组织样本。
BMC Med Genomics. 2019 Jan 31;12(Suppl 1):21. doi: 10.1186/s12920-018-0463-6.
10
DeepDSC: A Deep Learning Method to Predict Drug Sensitivity of Cancer Cell Lines.DeepDSC:一种用于预测癌细胞系药物敏感性的深度学习方法。
IEEE/ACM Trans Comput Biol Bioinform. 2021 Mar-Apr;18(2):575-582. doi: 10.1109/TCBB.2019.2919581. Epub 2021 Apr 6.

引用本文的文献

1
A pan-cancer, pan-treatment model for predicting drug responses from patient-derived xenografts.一种用于从患者来源的异种移植模型预测药物反应的泛癌、泛治疗模型。
NAR Genom Bioinform. 2025 Aug 28;7(3):lqaf111. doi: 10.1093/nargab/lqaf111. eCollection 2025 Sep.
2
PharmaFormer predicts clinical drug responses through transfer learning guided by patient derived organoid.PharmaFormer通过患者来源的类器官引导的迁移学习来预测临床药物反应。
NPJ Precis Oncol. 2025 Aug 13;9(1):282. doi: 10.1038/s41698-025-01082-6.
3
A disentangled generative model for improved drug response prediction in patients via sample synthesis.

本文引用的文献

1
Visualizing and interpreting cancer genomics data via the Xena platform.通过Xena平台可视化和解读癌症基因组学数据。
Nat Biotechnol. 2020 Jun;38(6):675-678. doi: 10.1038/s41587-020-0546-8.
2
Systematic identification of non-coding pharmacogenomic landscape in cancer.系统鉴定癌症中的非编码药物基因组学图谱。
Nat Commun. 2018 Aug 9;9(1):3192. doi: 10.1038/s41467-018-05495-9.
3
Kinase-targeted cancer therapies: progress, challenges and future directions.激酶靶向癌症疗法:进展、挑战与未来方向。
一种通过样本合成改进患者药物反应预测的解缠生成模型。
J Pharm Anal. 2025 Jun;15(6):101128. doi: 10.1016/j.jpha.2024.101128. Epub 2024 Oct 24.
4
Deep learning-driven drug response prediction and mechanistic insights in cancer genomics.深度学习驱动的癌症基因组学中的药物反应预测及机制洞察
Sci Rep. 2025 Jul 1;15(1):20824. doi: 10.1038/s41598-025-91571-2.
5
iGTP: learning interpretable cellular embedding for inferring biological mechanisms underlying single-cell transcriptomics.iGTP:学习可解释的细胞嵌入以推断单细胞转录组学背后的生物学机制。
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf296.
6
Large-scale information retrieval and correction of noisy pharmacogenomic datasets through residual thresholded deep matrix factorization.通过残差阈值深度矩阵分解对噪声药物基因组数据集进行大规模信息检索和校正。
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf226.
7
Computational limitations and future needs to unravel the full potential of 2'-O-methylation and C/D box snoRNAs.计算限制以及挖掘2'-O-甲基化和C/D盒小核仁RNA全部潜力的未来需求。
RNA Biol. 2025 Dec;22(1):1-11. doi: 10.1080/15476286.2025.2506712. Epub 2025 Jun 29.
8
Data imbalance in drug response prediction: multi-objective optimization approach in deep learning setting.药物反应预测中的数据不平衡:深度学习环境下的多目标优化方法
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf134.
9
A multi-task domain-adapted model to predict chemotherapy response from mutations in recurrently altered cancer genes.一种多任务域适应模型,用于根据复发性改变的癌症基因中的突变预测化疗反应。
iScience. 2025 Feb 11;28(3):111992. doi: 10.1016/j.isci.2025.111992. eCollection 2025 Mar 21.
10
Applications of Artificial Intelligence in Drug Repurposing.人工智能在药物重新定位中的应用。
Adv Sci (Weinh). 2025 Apr;12(14):e2411325. doi: 10.1002/advs.202411325. Epub 2025 Mar 6.
Mol Cancer. 2018 Feb 19;17(1):48. doi: 10.1186/s12943-018-0804-2.
4
Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies.基于化合物筛选的全基因组基因互作特征可预测靶向癌症疗法的临床疗效。
Cell Syst. 2018 Mar 28;6(3):343-354.e5. doi: 10.1016/j.cels.2018.01.009. Epub 2018 Feb 7.
5
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.集成网络细胞特征图谱 NIH 计划库:人类细胞对扰动反应的系统水平编目。
Cell Syst. 2018 Jan 24;6(1):13-24. doi: 10.1016/j.cels.2017.11.001. Epub 2017 Nov 29.
6
Tissue specificity of in vitro drug sensitivity.体外药物敏感性的组织特异性。
J Am Med Inform Assoc. 2018 Feb 1;25(2):158-166. doi: 10.1093/jamia/ocx062.
7
Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.通过从大型基因组学研究中推断癌症患者的药物反应来发现新的药物基因组生物标志物。
Genome Res. 2017 Oct;27(10):1743-1751. doi: 10.1101/gr.221077.117. Epub 2017 Aug 28.
8
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.干扰素-γ相关的mRNA谱可预测对PD-1阻断的临床反应。
J Clin Invest. 2017 Aug 1;127(8):2930-2940. doi: 10.1172/JCI91190. Epub 2017 Jun 26.
9
Role of tumor microenvironment in tumorigenesis.肿瘤微环境在肿瘤发生中的作用。
J Cancer. 2017 Feb 25;8(5):761-773. doi: 10.7150/jca.17648. eCollection 2017.
10
Kinase impact assessment in the landscape of fusion genes that retain kinase domains: a pan-cancer study.激酶融合基因景观中激酶活性评估:泛癌研究。
Brief Bioinform. 2018 May 1;19(3):450-460. doi: 10.1093/bib/bbw127.